Jeffrey Bland, PhD provides a mid-year 2014 update on Functional Medicine, summarizing the first half of the year’s focus on the evolution of the functional medicine model and development of a systems biology approach to personalize care and manage chronic illness. He outlines plans for the remainder of 2014 to emphasize molecular/orthomolecular interventions that apply systems biology principles to reduce risk and manage chronic disease.
Chapters
2014 Functional Medicine Update our 32nd year of unremitting and monthly additions, and this has been an extraordinary first half of the year. We really focused on two issues that are interrelated. The first was to discuss the evolution of the functional medicine model. Starting off with people like Dr. James Freese, who you've heard me quote so many times, his article in the New England Journal of medicine in 1980, aging, compression, morbidity and and natural death. And then moving from that into the second part of this first half of the year, the second quarter, which is to talk about the development of a systems biology approach to medicine, an extraordinary new development in the way that we're going to manage chronic illness and personalize health care. And now we'll move from that into the remainder of this year into what I consider kind of the molecular medicine application of these concepts. How do specific substances that are interventional in nature, that are orthomolecular, to use a Linus Pauling concept in their origin, meaning they're natural substances to the human body or to nature, modulate functions in ways that can both reduce the risk of and manage chronic illness? Built on this systems biology approach that we've been developing the first half of the year. This is a very exciting 2014 because it's a mini course, quite honestly, in the development of the new paradigm of medicine. So, so be with us throughout the remainder of 2014 to these exciting new developments in the application of systems biology and medicine.
